Animal stroke models: They are relevant to human disease

Stroke

Volumn 21, Issue 7, 1990, Pages 981-983

  Zivin, Justin A ^a   Grotta, James C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Animal models; Cerebrovascular disorders

Indexed keywords

CALCIUM ANTAGONIST; DIHYDROPYRIDINE DERIVATIVE; GLUTAMATE RECEPTOR ANTAGONIST; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL MODEL; CEREBROVASCULAR DISEASE; EDITORIAL; MAMMAL; NONHUMAN; PRIORITY JOURNAL; STROKE;

AGED; CEREBROVASCULAR DISORDERS; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; HUMAN; MALE;

EID: 0025332751     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.21.7.981     Document Type: Editorial

References (22)

1. Wiebers DO, Adams HP Jr., Whisnant JP: Animal models of stroke: Are they relevant to human disease? Stroke 1989; 21:1-3
2. Zivin J, Fisher M, DeGirolami U, Hemenway C, Stashak JA: Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 1985;230:1289-1292
3. Lyden PD, Zivin JA, Clark WA, Madden K, Sasse KC, Mazzarella VA, Terry RD, Press GA: Tissue plasminogen activator mediated thrombolysis of cerebral emboli and its effects on hemorrhagic infarction in rabbits. Neurology 1989; 39:703-708
4. Ozyurt E, Graham DI, Woodruff GN, McCulloch J: Protective effect of the glutamate antagonist MK-801 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 1988;8:138-143
5. Kochhar A, Zivin JA, Lyden PD, Mazzarella V: Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch Neural 1988; 45:148-153
6. Albers GW, Goldberg MR, Choi DW: N-methyl-D-aspartate antagonists: Ready for clinical trial in brain ischemia? Ann Neurol 1989;25:3 98-403
7. Olney JW, Labruyere J, Price MT: Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989;244:1360-1362
8. Kazda S, Hoffmeister F, Garthoff B, Towart R: Prevention of the postischemic impaired reperfusion of the brain by nimodipine (Bay e 9736). Acta Neuwl Scand 1979;72(suppl):302-303
9. Steen PA, Newberg IA, Milde JH, Michenfelder JD: Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1983;3:38-43
10. Grotta JC, Pettigrew LC, Rosenbaum D, Reid C, Rhoades H, McCandless D: Efficacy and mechanism of action of a calcium channel blocker after global cerebral ischemia in rats. Stroke 1988;19:447-454
11. Jacewicz M, Brint S, Tanabe J, Wange X, Pulsinelli W: Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal cerebral ischemia. J Cereb Blood Flow Metab 1990;10:89-96
12. Uematsu D, Greenberg JH, Hickey WF, Reivich M: Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke 1989;20:1531-1537
13. Lyden PD, Zivin JA, Kochhar A, Mazzarella V: Effects of calcium channel blockers on neurologic outcome after focal ischemia in rabbits. Stroke 1988;19:1020-1026
14. Mohr JP, Barnett HJM: Classification of ischemic stroke, in Barnett HJM, Stein BM, Mohr JP, Yatsu FM (eds): Stroke: Pathophysiology, Diagnosis and Management. New York, Churchill Livingstone, 1986, pp 281-291
15. Brott T, Haley C, Levy D, Barsan W, Sheppard G, Broderick J, Reed R, Marler J: Safety and potential efficacy of tissue plasminogen activator (tPA) for stroke (abstract). Stroke 1990; 21:181
16. Barsan WG, Brott TG, Olinger CP, Marler JR: Early treatment for acute ischemic stroke. Ann IntMed 1989;111:449-451
17. Sterman AB, Furlan AJ, Pessin M, Kase C, Caplan L, Williams G: Acute stroke therapy trials: An introduction to recurring design issues. Stroke 1987;18:524-527
18. Brott T, Marler JR, Olinger CP, Adams HP Jr, Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M: Measurement of acute cerebral infarction: Lesion size by computed tomography. Stroke 1989;20:871-875
19. Adams RJ, Meador KJ, Sethi KD, Grotta JC, Thomson DS: Graded neurologic scale for use in acute hemispheric stroke treatment protocols. Stroke 1987;18:665-669
20. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachin-ski V: The Canadian neurological scale: Validation and reliability assessment. Neurology 1989;39:638-643
21. Goldstein LB, BertelsC, Davis JN: Interrater reliability of the NIH stroke scale. Arch Neurol 1989;46:660-662
22. Feinstein AR: Clinimetrics. New Haven, Conn, Yale University Press, 1987